Merck secures Chinese obesity drug in nearly $2 billion deal

December 19, 2024No CommentsPosted inBusiness

Merck receives the exclusive worldwide license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read more

Source link

Spread the love

The 10-year Treasury yield rises to 4.5% as the Fed signals caution over future rate cuts

L.A.’s deputy mayor was placed on leave after the FBI raided his home over an alleged bomb threat

Comments

No comments yet. Why don’t you start the discussion?

Categories

Business
Entertainment
Fitness
Health
Sports
Tech
Top Stories

Stay ahead with breaking stories and in-depth analysis that uncover the truth behind the headlines. Our focus is your world—delivering timely, accurate, and impactful updates every day to keep you informed and empowered. From global events to local stories, we bring you the news that matters most, with clarity and integrity

Merck secures Chinese obesity drug in nearly $2 billion deal

Comments

Leave a Reply Cancel reply

Recent Posts

Recent News